Connection

YOCHAI BIRNBAUM to Angiotensin II Type 1 Receptor Blockers

This is a "connection" page, showing publications YOCHAI BIRNBAUM has written about Angiotensin II Type 1 Receptor Blockers.
  1. Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice. Cardiovasc Drugs Ther. 2011 Dec; 25(6):505-15.
    View in: PubMed
    Score: 0.361
  2. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size. Cardiovasc Drugs Ther. 2010 Apr; 24(2):107-20.
    View in: PubMed
    Score: 0.321
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.